EUVIMEDEUVIMED entdecken
Fallbericht

Hereditary Renal Tumor Syndromes and the Use of mTOR Inhibitors

José Luis Rodríguez-Olivares, Héctor Raúl González-Sánchez, Evelyn Lilian Beas-Lozano, Jazmin Arteaga-Vázquez, Elaine T Lam Md, María T Bourlon

ONCOLOGY · 2024

DOI: 10.46883/2024.25921027 ↗

Kurz gefasst

Fallbericht in der Zeitschrift ONCOLOGY, 2024. Verfasst von José Luis Rodríguez-Olivares und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Kidney Neoplasms, MTOR Inhibitors.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 47-year-old woman with a history of drug-resistant epilepsy during childhood presented to the emergency department with sudden dyspnea and chest pain. Upon admission, her oxygen saturation was 88%. A chest CT scan revealed pulmonary cystic lesions consistent with lymphangioleiomyomatosis and a right spontaneous pneumothorax, which resolved with the placement of a chest tube. Physical examination revealed a hypopigmented macule on the skin of the lumbar region, facial angiofibromas, and periungual fibromas. An abdominal MRI documented multiple bilateral renal tumors that were hypointense on T2-weighted imaging and showed a black boundary artifact, suggestive of fat-poor angiomyolipomas (AMLs). Subsequent percutaneous biopsy of the largest renal tumor confirmed the diagnosis of angiomyolipoma (positive for HMB-45 on immunohistochemistry). The brain MRI revealed subependymal nodules. The pulmonary function tests showed a mild obstructive pattern. Germline genetic testing confirmed the suspected diagnosis, and the patient started oral systemic treatment with everolimus (Afinitor) 10 mg once daily, along with dexamethasone rinses for prophylaxis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney NeoplasmsMTOR InhibitorsHumansFemaleMiddle AgedEverolimusAngiomyolipomaNeoplastic Syndromes, HereditaryTOR Serine-Threonine Kinases

Substanzen

MTOR InhibitorsEverolimusMTOR protein, humanTOR Serine-Threonine Kinases

Zitieren

APA

Rodríguez-Olivares, J. L., González-Sánchez, H. R., Beas-Lozano, E. L., Arteaga-Vázquez, J., Elaine T Lam Md, & Bourlon, M. T. (2024). Hereditary Renal Tumor Syndromes and the Use of mTOR Inhibitors. ONCOLOGY. https://doi.org/10.46883/2024.25921027

Vancouver

Rodríguez-Olivares JL, González-Sánchez HR, Beas-Lozano EL, Arteaga-Vázquez J, Elaine T Lam Md, Bourlon MT. Hereditary Renal Tumor Syndromes and the Use of mTOR Inhibitors. ONCOLOGY. 2024. doi:10.46883/2024.25921027

BibTeX
@article{RodrguezOlivares2024,
  author = {Rodríguez-Olivares, José Luis and González-Sánchez, Héctor Raúl and Beas-Lozano, Evelyn Lilian and Arteaga-Vázquez, Jazmin and Elaine T Lam Md and Bourlon, María T},
  title = {Hereditary Renal Tumor Syndromes and the Use of mTOR Inhibitors},
  journal = {ONCOLOGY},
  year = {2024},
  doi = {10.46883/2024.25921027}
}
Kostenlos starten →